224 related articles for article (PubMed ID: 10748100)
1. BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6.
Kimura N; Matsuo R; Shibuya H; Nakashima K; Taga T
J Biol Chem; 2000 Jun; 275(23):17647-52. PubMed ID: 10748100
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of BMP2-induced, TAK1 kinase-mediated neurite outgrowth by Smad6 and Smad7.
Yanagisawa M; Nakashima K; Takeda K; Ochiai W; Takizawa T; Ueno M; Takizawa M; Shibuya H; Taga T
Genes Cells; 2001 Dec; 6(12):1091-9. PubMed ID: 11737269
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.
Edlund S; Bu S; Schuster N; Aspenström P; Heuchel R; Heldin NE; ten Dijke P; Heldin CH; Landström M
Mol Biol Cell; 2003 Feb; 14(2):529-44. PubMed ID: 12589052
[TBL] [Abstract][Full Text] [Related]
4. Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis.
Hata K; Nishimura R; Ikeda F; Yamashita K; Matsubara T; Nokubi T; Yoneda T
Mol Biol Cell; 2003 Feb; 14(2):545-55. PubMed ID: 12589053
[TBL] [Abstract][Full Text] [Related]
5. Smad6 inhibits non-canonical TGF-β1 signalling by recruiting the deubiquitinase A20 to TRAF6.
Jung SM; Lee JH; Park J; Oh YS; Lee SK; Park JS; Lee YS; Kim JH; Lee JY; Bae YS; Koo SH; Kim SJ; Park SH
Nat Commun; 2013; 4():2562. PubMed ID: 24096742
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway.
Haÿ E; Lemonnier J; Fromigué O; Marie PJ
J Biol Chem; 2001 Aug; 276(31):29028-36. PubMed ID: 11395480
[TBL] [Abstract][Full Text] [Related]
7. Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells.
Ishisaki A; Yamato K; Hashimoto S; Nakao A; Tamaki K; Nonaka K; ten Dijke P; Sugino H; Nishihara T
J Biol Chem; 1999 May; 274(19):13637-42. PubMed ID: 10224135
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression.
Hanafusa H; Ninomiya-Tsuji J; Masuyama N; Nishita M; Fujisawa J; Shibuya H; Matsumoto K; Nishida E
J Biol Chem; 1999 Sep; 274(38):27161-7. PubMed ID: 10480932
[TBL] [Abstract][Full Text] [Related]
9. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE
Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162
[TBL] [Abstract][Full Text] [Related]
10. TGF-β-activated kinase 1 (Tak1) mediates agonist-induced Smad activation and linker region phosphorylation in embryonic craniofacial neural crest-derived cells.
Yumoto K; Thomas PS; Lane J; Matsuzaki K; Inagaki M; Ninomiya-Tsuji J; Scott GJ; Ray MK; Ishii M; Maxson R; Mishina Y; Kaartinen V
J Biol Chem; 2013 May; 288(19):13467-80. PubMed ID: 23546880
[TBL] [Abstract][Full Text] [Related]
11. ASK1 inhibits interleukin-1-induced NF-kappa B activity through disruption of TRAF6-TAK1 interaction.
Mochida Y; Takeda K; Saitoh M; Nishitoh H; Amagasa T; Ninomiya-Tsuji J; Matsumoto K; Ichijo H
J Biol Chem; 2000 Oct; 275(42):32747-52. PubMed ID: 10921914
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells.
Watanabe H; de Caestecker MP; Yamada Y
J Biol Chem; 2001 Apr; 276(17):14466-73. PubMed ID: 11278290
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta-activated kinase-1 (TAK1), a MAP3K, interacts with Smad proteins and interferes with osteogenesis in murine mesenchymal progenitors.
Hoffmann A; Preobrazhenska O; Wodarczyk C; Medler Y; Winkel A; Shahab S; Huylebroeck D; Gross G; Verschueren K
J Biol Chem; 2005 Jul; 280(29):27271-83. PubMed ID: 15911626
[TBL] [Abstract][Full Text] [Related]
14. Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts.
Nöth U; Tuli R; Seghatoleslami R; Howard M; Shah A; Hall DJ; Hickok NJ; Tuan RS
Exp Cell Res; 2003 Nov; 291(1):201-11. PubMed ID: 14597420
[TBL] [Abstract][Full Text] [Related]
15. Regulation of MAP kinase by the BMP-4/TAK1 pathway in Xenopus ectoderm.
Goswami M; Uzgare AR; Sater AK
Dev Biol; 2001 Aug; 236(2):259-70. PubMed ID: 11476570
[TBL] [Abstract][Full Text] [Related]
16. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
Itoh F; Asao H; Sugamura K; Heldin CH; ten Dijke P; Itoh S
EMBO J; 2001 Aug; 20(15):4132-42. PubMed ID: 11483516
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the interleukin-1-induced signaling pathways by a novel member of the protein phosphatase 2C family (PP2Cepsilon).
Li MG; Katsura K; Nomiyama H; Komaki K; Ninomiya-Tsuji J; Matsumoto K; Kobayashi T; Tamura S
J Biol Chem; 2003 Apr; 278(14):12013-21. PubMed ID: 12556533
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein-2 inhibits serum deprivation-induced apoptosis of neonatal cardiac myocytes through activation of the Smad1 pathway.
Izumi M; Fujio Y; Kunisada K; Negoro S; Tone E; Funamoto M; Osugi T; Oshima Y; Nakaoka Y; Kishimoto T; Yamauchi-Takihara K; Hirota H
J Biol Chem; 2001 Aug; 276(33):31133-41. PubMed ID: 11408477
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta-Smad signaling pathway negatively regulates nontypeable Haemophilus influenzae-induced MUC5AC mucin transcription via mitogen-activated protein kinase (MAPK) phosphatase-1-dependent inhibition of p38 MAPK.
Jono H; Xu H; Kai H; Lim DJ; Kim YS; Feng XH; Li JD
J Biol Chem; 2003 Jul; 278(30):27811-9. PubMed ID: 12734193
[TBL] [Abstract][Full Text] [Related]
20. The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.
Sorrentino A; Thakur N; Grimsby S; Marcusson A; von Bulow V; Schuster N; Zhang S; Heldin CH; Landström M
Nat Cell Biol; 2008 Oct; 10(10):1199-207. PubMed ID: 18758450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
